Skip to main content
. 2011 Nov 11;14(5):709–714. doi: 10.1093/europace/eur347

Figure 3.

Figure 3

One-year Kaplan–Meier survival estimates for survival free of recurrent implantable cardioverter defibrillator shocks/ATP therapies for sustained ventricular tachycardia. There was no significant differences noted in survival-free event rates (log rank P value=0.96).